Document is current
Any future updates will be listed below
-
Authors
Nakamura, Kyohei https://orcid.org/0000-0002-6631-9028
Smyth, Mark J.
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1173958, 1132519)
Leukemia Foundation of Australia
Naito Foundation
- License Information
-
More Information
Article History
Received: 2 September 2020
Revised: 14 September 2020
Accepted: 15 September 2020
First Online: 9 October 2020
Competing interests
: M.J.S. has research agreements with Bristol Myers Squibb and Tizona Therapeutics and is a member of the Scientific Advisory Board (SAB) for Tizona Therapeutics and Compass Therapeutics.
